Skip to main content

Table 1 List and characteristics of studies on human cystic echinococcosis in Africa

From: Africa-wide meta-analysis on the prevalence and distribution of human cystic echinococcosis and canine Echinococcus granulosus infections

Country

Study year

MOD

Sample size

Cases

Prev. (%)

95% CI

ROB

Study reference

C/Africa

 Gabon

2014–16

US

348

0

0.00

0.00, 1.05

MR

Lotsch et al. [59]

E/Africa

 Ethiopia

2008–12

US

25,840

27

0.10

0.07, 0.15

LR

Assefa et al. [60]

 Ethiopia

1980

IHT

1342

68

3.49

2.60, 4.57

MR

Fuller and Fuller [61]

 Ethiopia

2002–06

US

36,402

26

0.07

0.05, 0.10

MR

Kebede et al. [62]

 Ethiopia

1989

US

990

7

6.41

5.16, 7.85

MR

Klungsoyr et al. [63]

 Ethiopia, Kenya, South Sudan and Tanzania

1985–87

US

18,565

332

1.79

1.60, 1.99

MR

Macpherson et al. [64]

 Kenya

1981/82

IHT

1190

85

7.14

5.74, 8.76

 

French and Ingera [65]

 Kenya

1991

ELISA

538

88

16.36

13.33, 19.76

MR

Kenny and MacCabe [66]

 Kenya

1986

USS/ELISA

3553

198

5.57

4.84, 6.38

MR

Macpherson et al. [67]

 Kenya

1983–15

US

961

240

24.97

22.27, 27.84

MR

Solomon et al. [68]

 Kenya

1985–12

US

10,920

418

3.83

3.48, 4.20

MR

Solomon et al. [69]

 Mozambique

2011/11

MWB

601

104

17.30

14.36, 20.57

MR

Noormahomed et al. [70]

 South Sudan

2012

USS

610

4

0.66

0.18, 1.67

MR

Stewart et al. [71]

 Tanzania

2012

ELISA

345

39

11.30

8.16, 15.13

MR

Khan et al. [72]

 Tanzania

1977–86

US

959

10

1.04

0.50, 1.91

MR

Macpherson et al. [73]

N/Africa

 Egypt

1974

LAT

755

47

6.23

4.61, 8.19

MR

Botros et al. [74]

 Egypt

1997–99

MRI, US & X-ray

492,353

133

0.03

0.02, 0.03

MR

Kandeel et al. [75]

 Egypt

2006

IHT

21

3

14.29

3.05, 36.34

MR

Mazyat et al. [76]

 Libya

1972–79

Surgical

22,979

111

0.48

0.40, 0.58

MR

Aboundaya [77]

 Libya

1979–80

ELISA

217

20

9.22

5.72, 13.88

 

Gebreel et al. [78]

 Libya

1989

IHT

384

8

0.36

0.13, 0.79

MR

Khan et al. [79]

 Libya

2008–11

ELISA

300

27

9.00

6.01, 12.82

LR

Mohamed et al. [80]

 Libya

1991

US

4103

57

1.39

1.05, 1.81

MR

Shambesh et al. [81]

 Libya

1996

US

485

22

4.54

2.86, 6.79

MR

Shambesh et al. [82]

 Libya

1998

US

20,220

339

1.68

1.50, 1.86

MR

Shambesh et al. [83]

 Morocco

2014

US

5367

102

1.90

1.55, 2.30

LR

Chebil et al. [84]

 Morocco

2000/01

US

11,612

126

1.09

0.90, 1.29

MR

Macpherson et al. [85]

 Sudan

2017/18

ELISA

305

20

6.56

4.05, 9.95

LR

Ahmed et al. [86]

 Sudan

2002

US

300

1

0.33

0.01, 1.84

LR

Elmahdi et al. [87]

 Tunisia

1980–84

ELISA

355

8

2.25

0.98, 4.39

MR

Bchir et al. [88]

 Tunisia

1990

US

1434

50

1.34

0.62, 2.53

MR

Bchir et al. [89]

 Tunisia

1990–17

US

7808

26

0.33

0.22, 0.49

MR

Jomaa et al. [90]

 Tunisia

2004–09

Autopsy

2155

26

2.08

0.90, 4.06

MR

Khelil et al. [91]

 Tunisia

2018

ELISA

374

32

8.56

5.93, 11.86

MR

M’rad et al. [92]

 Tunisia

1983

US

670

9

0.57

0.01, 3.13

MR

Mlika et al. [93]

 Tunisia

1985

US/ELISA

1650

6

13.12

9.41, 17.63

MR

Mlika et al. [94]

S/Africa

 South Africa

1995–10

IHT

236

26

11.02

7.32, 15.72

MR

Wahlers et al. [12]

W/Africa

 Nigeria

1977

AGDT and IHT

189,861

1

0.00

0.00, 0.00

MR

Dada [95]

 Nigeria

1986

CFT

176

1

1.21

0.79, 1.76

MR

Sixl et al. [96]

  1. AGDT Agar gel diffusion test, CFT complement fixation test, CI confidence interval, C/Africa Central Africa, E/Africa eastern Africa, ELISA enzyme-linked immunosorbent assay, IHT indirect hemagglutination test, LAT latex agglutination test, LR low risk, MR moderate risk, MRI magnetic resonance imaging, MWB multiplex western blot, N/Africa northern Africa, ROB risk of bias, S/Africa southern Africa, US ultrasonography, W/Africa western Africa